Gossamer Bio, Inc.

Gossamer Bio, Inc.verified

GOSS

Price:

$0.1619

Market Cap:

$38.00M

Gossamer Bio, Inc. operates as a U.S.-based, clinical-stage biopharmaceutical company. Its primary objective is to discover, acquire, advance, and market novel therapeutic solutions, specifically addressing conditions within immunology, inflammatory diseases, and oncology. The company's pipeline highlights several key drug candidates: GB002: An inhaled small molecule designed to inhibit platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor (CSF1R), and c-KIT, currently being developed for pulmonary arterial hypertension. GB004: An oral, gut-targeted small molecule in development for treating inflammatory bowel disease. GB5121: An oral, irreversible covalent sm...[Read more]

Industry

Biotechnology

IPO Date

2019-02-08

Stock Exchange

NASDAQ

Ticker

GOSS

The Enterprise Value as of June 2026 (TTM) for Gossamer Bio, Inc. (GOSS) is 199.90M

According to Gossamer Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 199.90M. This represents a change of -66.05% compared to the average of 588.78M of the last 4 quarters.

Gossamer Bio, Inc. (GOSS) Historical Enterprise Value (quarterly & annually)

How has GOSS Enterprise Value performed in the past?

The mean historical Enterprise Value of Gossamer Bio, Inc. over the last ten years is 548.01M. The current 199.90M Enterprise Value has changed 3.55% with respect to the historical average. Over the past ten years (40 quarters), GOSS's Enterprise Value was at its highest in in the June 2019 quarter at 1.25B. The Enterprise Value was at its lowest in in the March 2017 quarter at 0.

Quarterly (TTM)
Annual

Average

548.01M

Median

418.69M

Minimum

164.33M

Maximum

978.39M

Gossamer Bio, Inc. (GOSS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Gossamer Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 174.57%

Maximum Annual Enterprise Value = 978.39M

Minimum Annual Increase = -64.95%

Minimum Annual Enterprise Value = 164.33M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025872.65M141.43%
2024361.45M-6.41%
2023386.19M29.90%
2022297.29M-64.95%
2021848.31M135.53%
2020360.17M-52.62%
2019760.11M-22.31%
2018978.39M116.84%
2017451.20M174.57%

Gossamer Bio, Inc. (GOSS) Average Enterprise Value

How has GOSS Enterprise Value performed in the past?

The current Enterprise Value of Gossamer Bio, Inc. (GOSS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

540.10M

5-year avg

553.18M

10-year avg

548.01M

Gossamer Bio, Inc. (GOSS) Enterprise Value vs. Peers

How is GOSS’s Enterprise Value compared to its peers?

Gossamer Bio, Inc.’s Enterprise Value is less than KalVista Pharmaceuticals, Inc. (1.49B), less than 4D Molecular Therapeutics, Inc. (409.65M), less than Olema Pharmaceuticals, Inc. (810.53M), less than Ventyx Biosciences, Inc. (982.56M), less than Lexicon Pharmaceuticals, Inc. (872.47M), less than Rigel Pharmaceuticals, Inc. (629.10M), greater than Prothena Corporation plc (110.11M), less than Corvus Pharmaceuticals, Inc. (963.93M), less than RAPT Therapeutics, Inc. (923.92M), less than REGENXBIO Inc. (400.14M),

Build a custom stock screener for Gossamer Bio, Inc. (GOSS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gossamer Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gossamer Bio, Inc. (GOSS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gossamer Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Gossamer Bio, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Gossamer Bio, Inc. (GOSS)?

What is the 3-year average Enterprise Value for Gossamer Bio, Inc. (GOSS)?

What is the 5-year average Enterprise Value for Gossamer Bio, Inc. (GOSS)?

How does the current Enterprise Value for Gossamer Bio, Inc. (GOSS) compare to its historical average?